Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

118
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
118
Randomized Experiments01:13

Randomized Experiments

6.7K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Odds Ratio01:09

Odds Ratio

105
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
105

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial.

Scientific reports·2026
Same author

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.

The New England journal of medicine·2026
Same author

Prevention of secondary infections by interferon-gamma in ICU-acquired sustained immune suppression in France: study protocol of the PLATINIUM randomised trial.

BMJ open·2026
Same author

Consensus for the most suitable trial design to assess therapy for rare vascular malformations: a Delphi study.

Scientific reports·2026
Same author

Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.

BMJ (Clinical research ed.)·2026
Same author

Process evaluation of a school-based vaccination intervention to improve HPV vaccine coverage: A mixed-method study embedded in the French PrevHPV cluster randomized controlled trial.

Vaccine·2025

Related Experiment Video

Updated: Jun 8, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Estimating an adjusted risk difference in a cluster randomized trial with individual-level analyses.

Jules Antoine Pereira Macedo1, Bruno Giraudeau1,2, Escient Collaborators

  • 1Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France.

Statistical Methods in Medical Research
|November 6, 2024
PubMed
Summary

Estimating risk differences in cluster randomized trials (CRTs) is crucial. Simulation results suggest the Gaussian distribution with generalized estimating equations (GEE) offers a robust and straightforward method for calculating intervention effects.

Keywords:
binary outcomecluster randomized trialg-computationgeneralized estimating equationsgeneralized linear mixed modelsrisk difference

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

Related Experiment Videos

Last Updated: Jun 8, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Epidemiology

Background:

  • Cluster randomized trials (CRTs) often report odds ratios for binary outcomes.
  • The CONSORT statement recommends reporting both relative and absolute intervention effects.
  • Estimating absolute intervention effects like risk difference (RD) in CRTs requires careful methodological consideration.

Purpose of the Study:

  • To evaluate methods for estimating risk difference (RD) in cluster randomized trials (CRTs).
  • To compare conditional (GLMM) and marginal (GEE) approaches using Gaussian, binomial, and Poisson distributions.
  • To assess bias, standard error estimation, type I error, and coverage rates.

Main Methods:

  • A simulation study was conducted within the framework of CRTs.
  • Methods included generalized linear mixed models (GLMM) and generalized estimating equations (GEE).
  • Distributions considered were Gaussian, binomial, and Poisson, with g-computation for binomial/Poisson RD estimation.

Main Results:

  • All methods demonstrated no bias in risk difference estimation.
  • GEE approach experienced convergence issues under specific conditions (low ICC, few clusters, small cluster size, many covariates, low prevalence).
  • Gaussian distribution (both approaches) and GEE (binomial/Poisson) showed satisfactory standard error estimation; GEE outperformed GLMM in type I error and coverage.

Conclusions:

  • The Gaussian distribution is recommended for its simplicity in estimating RD in CRTs.
  • The GEE approach is generally preferred over GLMM due to better performance in type I error and coverage.
  • GLMM may be used when GEE encounters convergence problems.